0001214659-12-000632.txt : 20120214 0001214659-12-000632.hdr.sgml : 20120214 20120214140822 ACCESSION NUMBER: 0001214659-12-000632 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111231 FILED AS OF DATE: 20120214 DATE AS OF CHANGE: 20120214 EFFECTIVENESS DATE: 20120214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TANG CAPITAL MANAGEMENT LLC CENTRAL INDEX KEY: 0001232621 IRS NUMBER: 680517275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-14822 FILM NUMBER: 12607605 BUSINESS ADDRESS: STREET 1: 4401 ESTGATE MALL CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582003830 MAIL ADDRESS: STREET 1: 4401 EASTGATE MALL CITY: SAN DIEGO STATE: CA ZIP: 92121 13F-HR 1 c21412013fhr.txt REPORT FOR THE CALENDAR YEAR ENDED DECEMBER 31, 2011 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: December 31, 2011 Check here if Amendment [ ]; Amendment Number: __ This Amendment (Check only one): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Tang Capital Management, LLC Address: 4747 Executive Drive, Suite 510, San Diego, CA 92121 Form 13F File Number: The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Kevin C. Tang Title: Managing Director of Tang Capital Management, LLC Phone: 858-200-3830 Signature, Place, and Date of Signing: /s/ Kevin C. Tang San Diego, CA February 14, 2012 ----------------------- ------------------------ ------------------------- [Signature] [City, State] [Date] Report Type (Check only one.): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [_] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [_] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: NONE FORM 13F SUMMARY PAGE REPORT SUMMARY: NUMBER OF OTHER INCLUDED MANAGERS: 1 FORM 13F INFORMATION TABLE ENTRY TOTAL: 29 FORM 13F INFORMATION TABLE VALUE TOTAL: 356,107 (thousands) LIST OF OTHER INCLUDED MANAGERS: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. 1 Kevin C. Tang 028-14818
FORM 13F INFORMATION TABLE VALUE SHARES/ SH/ PUT/ INVSTMT OTHER VOTING AUTHORITY NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DSCRETN MANAGERS SOLE SHARED NONE ACHILLION PHARMACEUTICALS INC COM 00448Q201 7,138 936,800 SH SOLE 936,800 0 0 AFFYMETRIX INC NOTE 3.500% 1/15/38 00826TAG3 70,769 70,829,000 PRN SOLE 70,829,000 0 0 AFFYMETRIX INC NOTE 3.500% 1/15/38 00826TAG3 520 520,000 PRN SHARED- 1 204,000 214,000 102,000 DEFINED ARDEA BIOSCIENCES INC COM 03969P107 55,593 3,307,112 SH SOLE 3,307,112 0 0 ARDEA BIOSCIENCES INC COM 03969P107 3,499 208,177 SH SHARED- 1 82,141 114,036 12,000 DEFINED AVANIR PHARMACEUTICALS INC COM 05348P401 3,198 1,560,223 SH SOLE 1,560,223 0 0 BIOMARIN PHARMACEUTICALS INC NOTE 2.500% 3/29/13 09061GAC5 6,296 3,000,000 PRN SOLE 3,000,000 0 0 CADENCE PHARMACEUTICALS INC COM 12738T100 1,943 491,953 SH SOLE 491,953 0 0 CYCLACEL PHARMACEUTICALS INC PFD CONV EX 6% 23254L207 792 277,993 SH SOLE 277,993 0 0 DENDREON CORP COM 24823Q107 605 79,600 SH SHARED- 1 0 79,600 0 DEFINED DENDREON CORP NOTE 4.750% 6/15/14 24823QAB3 3,560 4,000,000 PRN SOLE 4,000,000 0 0 DENDREON CORP NOTE 2.875% 1/15/16 24823QAC1 6,847 9,815,000 PRN SOLE 9,815,000 0 0 DEPOMED INC COM 249908104 14,339 2,768,145 SH SOLE 2,768,145 0 0 ENDOCYTE INC COM 29269A102 1,751 465,763 SH SOLE 465,763 0 0 INTERMUNE INC NOTE 2.500% 9/15/18 45884XAE3 12,495 17,000,000 PRN SOLE 17,000,000 0 0 MANNKIND CORP COM 56400P201 82 32,888 SH SOLE 32,888 0 0 MANNKIND CORP NOTE 3.750% 12/15/13 56400PAA0 11,832 22,325,000 PRN SOLE 22,325,000 0 0 MANNKIND CORP PUT 56400P951 3,419 12,389 PUT SOLE 12,389 0 0 NEKTAR THERAPEUTICS INC NOTE 3.250% 9/28/12 640268AH1 68,334 69,907,000 PRN SOLE 69,907,000 0 0 NEOPROBE CORP COM 640518106 647 246,984 SH SOLE 246,984 0 0 OPKO HEALTH INC COM 68375N103 490 100,000 SH SOLE 100,000 0 0 OPTIMER PHARMACEUTICALS INC COM 68401H104 12,916 1,055,205 SH SOLE 1,055,205 0 0 PDL BIOPHARMA INC NOTE 2.875% 2/15/15 69329YAA2 39,509 37,474,000 PRN SOLE 37,474,000 0 0 SALIX PHARMACEUTICALS INC NOTE 5.500% 8/15/28 795435AB2 15,510 3,000,000 PRN SOLE 3,000,000 0 0 SAVIENT PHARMACEUTICALS COM 80517Q100 1,755 787,200 SH SOLE 787,200 0 0 SAVIENT PHARMACEUTICALS INC NOTE 4.750% 1/31/18 80517QAA8 4,300 10,000,000 PRN SOLE 10,000,000 0 0 SOMAXON PHARMACEUTICALS INC COM 834453102 504 1,119,602 SH SOLE 1,119,602 0 0 UNITED THERAPEUTICS CORP COM 91307C102 4,725 100,000 SH SOLE 100,000 0 0 VIROPHARMA INC COM 928241108 2,739 100,000 SH SOLE 100,000 0 0